NASDAQ: RLMD
Relmada Therapeutics Inc Earnings Dates, Reports, Calls

Relmada Therapeutics earnings were -$86.5M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest RLMD earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$21.7M, up 22.3% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, RLMD reported annual earnings of -$98.8M, with -37.1% growth. The next RLMD earnings date is Mar 17, 2025.

RLMD earnings history

Current Revenue
$0.0
Current Earnings
-$86.5M
Current Profit Margin
0%

RLMD Return on Equity

Current Company
-129.8%
Current Industry
19.9%
Current Market
35%
RLMD's Return on Equity (-129.8%)... subscribe to Premium to read more.
High Return on Equity Performance

RLMD undefined

Current Company
-112.1%
Current Industry
1.3%
RLMD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when RLMD announces earnings.

RLMD undefined

Current Company
-181.55%
Current Industry
14.3%
RLMD's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RLMD vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
RLMD-$86.49M-$86.49MN/A-$2.86
EVGN-$17.67M-$23.51MN/A-$4.42
TSBX-$73.22M-$74.42MN/A-$2.27
BCLI-$13.38M-$14.23MN/A-$3.51
XTLB-$1.78M-$1.78MN/A-$0.30

RLMD earnings dates

Next earnings date
Mar 17, 2025

Relmada Therapeutics Earnings Reports & History FAQ

What were Relmada Therapeutics's earnings last quarter?

On RLMD's earnings call on Invalid Date, Relmada Therapeutics (NASDAQ: RLMD) reported Q3 2024 earnings per share (EPS) of -$0.72, up 1.37% year over year. Total RLMD earnings for the quarter were -$21.73 million. In the same quarter last year, Relmada Therapeutics's earnings per share (EPS) was -$0.73.

If you're new to stock investing, here's how to buy Relmada Therapeutics stock.

When does Relmada Therapeutics report earnings?

The next RLMD earnings call is Invalid Date. Add RLMD to your watchlist to be reminded of Relmada Therapeutics's next earnings date.

What was RLMD's earnings growth in the past year?

As of Relmada Therapeutics's earnings date in Invalid Date, Relmada Therapeutics's earnings has grown year over year. RLMD earnings in the past year totalled -$86.49 million.

Is Relmada Therapeutics profitable or losing money?

As of the last Relmada Therapeutics earnings report, Relmada Therapeutics is currently losing money. Relmada Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$86.49 million, a 22.48% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.